MAPK10 and hepatocellular carcinoma: Also cumulative scoring showed that HCC patients in the high-MAPK10 group had significantly higher immune cell expression signatures than those in the low-MAPK10 group (Wilcoxon test, P = 3.429 × 10−6; Figure 2D).